{
    "2018-03-28": [
        [
            {
                "time": "",
                "original_text": "泰格医药(300347)：CRO巨头药明康德过会 板块公司受益",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "药明康德",
                        "CRO",
                        "过会",
                        "板块受益"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健行业热点速评：药明康德过会 关注CRO & CMO投资机会",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "药明康德",
                        "过会",
                        "CRO",
                        "CMO",
                        "投资机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健",
                        "CRO",
                        "CMO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}